The International Council for Harmonisation (ICH): 'E' group of guidelines

Below is the overview of 'E' group of ICH guidelines that collectively apply to different stages and types of pre- / clinical research and development.

 

ICH: ‘E’ group of guidelines overview

 

General Considerations for Clinical Studies:

E 8 (R1) ICH Consensus Guideline

 

Design and Analysis:

E4 Dose-Response Studies

E9 Statistical principles for Clinical Trials

E10 Choice of Control Group in Clinical Trials

E17 Multi-Regional Clinical Trials

Conduct and Reporting:

E3 Clinical Study Reports

Safety Reporting:

E1 Clinical Safety for Drugs used in Long-Term Treatment

E2A – E2F Pharmacovigilance

E14 Clinical Evaluation of QT

E19 Safety Data Collection

 

Populations:

E5 Ethnic Factors

E7 Clinical Trials in Geriatric Population

E11 – E11A Clinical Trials in Pediatric Polulations

E12 Clinical Evaluation by Therapeutic Category

Genetics / Genomics

E15 Definitions in Pharmacogenetics/Pharmacogenomics

E16 Qualification of Genomic Biomarkers

E18 Genomic Sampling

 

Other EU Guidelines:

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

 

 

Author: European Medicines Agency

Clinical Research News

Could treating food allergy before age 2 help children develop lasting tolerance?
Could a diabetes and obesity drug help treat methamphetamine addiction?
Beyond Oral Pills: Can a Once-Daily Inhaler Slow Progressive Lung Scarring?
From cancer to Alzheimer’s: nine medical advances and trials to watch now
Can Two Pills Beat Chemotherapy? Targeted Combination for Pancreatic Cancer Enters Phase 3
GSK Moves mRNA Flu Vaccine Into 54,000-Person Phase 3 Trial in Adults 65 and Older
The End of Weight-Loss Injections? AstraZeneca’s Daily Pill Enters Phase III Trials

Kommende kliniske studier

Clinical Research Jobs

More jobs

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

Abonnere